We are happy to announce that in addition to one-on-one consulting, workshops, and seminars, we are now adding webinars to our menu of options to help NIH grantees. Upcoming webinars: Mistakes Commonly Made On NIH Grant Applications Benefit from the knowledge gained by a grantwriter who reads dozens of Summary Statements per year. Wednesday 4 […]
NIH Grantwriting Webinar Series Begins in February 2015! Read More »
For years, grantees have been encouraged to use a shared IRB in multi-site clinical trials as part of shared research networks at NCI, and it appears to increase efficiency without compromising protection. In early December 2014, NIH released a draft policy proposing that multi-site trials in the U.S. be required to use a single IRB.
NIH Issues Draft Policy That Would Require A Single IRB For Multi-Site Clinical Trials Read More »
Remember ketamine, the old veterinary (and sometimes street) drug? Apparently it rapidly and significantly reduces anhedonia in those with treatment-resistant bipolar disorder, according to a new study. Anhedonia, which is a lack of interest in activities that once gave a person pleasure, is a key feature of treatment-resistant bipolar disorder. According to a recent NIH-funded
Ketamine — A New Drug Treatment For Depression? Read More »
